The role of the QPPV demands oversight responsibilities across the global pharmacovigilance system. Current trends for – often misaligned - local pharmacovigilance regulations, multiple CRO/partner engagements, and the raise of digital health make managing pharmacovigilance across the globe an increasingly difficult task.
This session will provide some examples on how these challenges can be approached, and how technology can be used to optimise the information flow.
Pilar Carrero (MD, PhD) is VicePresident for the QPPV Office at Novo Nordisk in Denmark.
Dr Carrero has 19 years of experience in the pharmaceutical industry ranging from management of Discovery research projects to broad experience in pharmacovigilance with a keen interest in the IT developments within pharmacovigilance and their impact. Responsible for setting up new organisational functions, most recently the QPPV Office which supports the QPPV, the different headquarters safety functions and Affiliates globally.
Prior to her work in Novo Nordisk, Dr Carrero obtained her degree in Medicine and PhD in Biochemistry in Madrid (Spain), and then she worked as a researcher at Karolinska Institute in Stockholm (Sweden).